Assetmark Inc. Has $432,000 Position in Waters Co. (NYSE:WAT)

Assetmark Inc. grew its stake in Waters Co. (NYSE:WAT) by 16.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,200 shares of the medical instruments supplier’s stock after purchasing an additional 170 shares during the period. Assetmark Inc.’s holdings in Waters were worth $432,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of WAT. Itau Unibanco Holding S.A. acquired a new position in Waters during the second quarter worth $33,000. Blue Trust Inc. grew its holdings in shares of Waters by 190.2% in the 2nd quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 78 shares during the last quarter. TFC Financial Management Inc. increased its position in shares of Waters by 19,900.0% during the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after purchasing an additional 199 shares in the last quarter. Federated Hermes Inc. bought a new position in Waters during the 2nd quarter valued at about $59,000. Finally, Family Firm Inc. bought a new stake in Waters during the second quarter worth about $90,000. Institutional investors own 94.01% of the company’s stock.

Waters Price Performance

Shares of WAT stock opened at $358.46 on Friday. The firm has a market capitalization of $21.28 billion, a price-to-earnings ratio of 34.20, a price-to-earnings-growth ratio of 6.89 and a beta of 0.97. Waters Co. has a 12-month low of $258.89 and a 12-month high of $393.38. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. The firm has a fifty day moving average of $350.75 and a 200-day moving average of $330.58.

Waters (NYSE:WAT) last released its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $2.68 by $0.25. Waters had a return on equity of 49.93% and a net margin of 21.43%. The company had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. During the same quarter last year, the firm posted $2.84 earnings per share. Waters’s revenue was up 4.0% compared to the same quarter last year. On average, equities research analysts forecast that Waters Co. will post 11.79 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Barclays lifted their price objective on Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a research report on Monday, November 4th. Leerink Partnrs upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft boosted their price objective on Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Evercore ISI raised their price objective on shares of Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, Stifel Nicolaus lifted their target price on shares of Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $365.85.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.